DCM
TWST icon

Discovery Capital Management’s Twist Bioscience TWST Stock Holding History

Discovery Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-37,500
Closed -$1.85M – 85
2022
Q1 		$1.85M Buy
+37,500
New +$2.08M 0.16% 65

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Discovery Capital Management's TWST Position: Q2 2022 in Review

Discovery Capital Management sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 37,500 shares — an estimated $1.85M sold.

Discovery Capital Management first reported a position in TWST in Q1 2022 and held it in 1 quarter. The position peaked at $1.85M in Q1 2022. 203 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

  • Discovery Capital Management reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
  • Discovery Capital Management sold 37,500 Twist Bioscience shares in Q2 2022, an estimated $1.85M.
  • Discovery Capital Management first reported a position in Twist Bioscience in Q1 2022 and held it in 1 quarter.
  • Discovery Capital Management's Twist Bioscience position peaked at $1.85M in Q1 2022.
  • 203 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Discovery Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.